Ghent University Academic Bibliography

Your filters: cql: author="Kamat, Siddhesh" or (type any "bookEditor issueEditor" and editor="Kamat, Siddhesh")

Add to list
- Journal Article
- A1
- open access
Dupilumab efficacy across serum IgE and blood eosinophil levels in chronic rhinosinusitis with nasal polyposis

Claus Bachert (UGent) , Philippe Gevaert (UGent) , Brian Lipworth, Syed Shahzad Mustafa, Andrew P. Lane, Joaquim Mullol, Paul Rowe, Yamo Deniz, Siddhesh Kamat, Asif H. Khan, et al.

(2024) ALLERGY. 79(10). p.2858-2861
Add to list
- Journal Article
- A1
- open access
Dupilumab provides early and durable improvement of symptoms in patients with chronic rhinosinusitis with nasal polyps

Philippe Gevaert (UGent) , Stella E Lee, Russell A Settipane, Martin Wagenmann, Jérôme Msihid, Shahid Siddiqui, Scott Nash, Juby A Jacob‐Nara, Asif Khan, Siddhesh Kamat, et al.

(2023) CLINICAL & TRANSLATIONAL IMMUNOLOGY. 12(1).
Add to list
- Journal Article
- A1
- open access
Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma

Eric D Bateman, Asif H. Khan, Yingxin Xu, Patricia Guyot, Jingdong Chao, Siddhesh Kamat, Paul Rowe, Heather Burnett, Jerome Msihid and David Weinreich

(2022) RESPIRATORY MEDICINE. 191.
Add to list
- Journal Article
- A1
Response to comment on : Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma (Respir. Med. 2020)

Eric D Bateman, Asif H. Khan, Yingxin Xu, Patricia Guyot, Jingdong Chao, Siddhesh Kamat, Heather Burnett, Jerome Msihid, David M Weinreich and Ian Pavord

(2022) RESPIRATORY MEDICINE. 191.
Add to list
- Journal Article
- A1
- open access
Development of Sinonasal Outcome Test (SNOT-22) domains in chronic rhinosinusitis with nasal polyps

Asif H. Khan, Matthew Reaney, Isabelle Guillemin, Lauren Nelson, Shanshan Qin, Siddhesh Kamat, Leda Mannent, Nikhil Amin, Diane Whalley and Claire Hopkins

(2022) LARYNGOSCOPE. 132(5). p.933-941
Add to list
- Journal Article
- A1
- open access
Dupilumab improves health related quality of life : results from the phase 3 SINUS studies

Stella E Lee, Claire Hopkins, Joaquim Mullol, Jérôme Msihid, Isabelle Guillemin, Nikhil Amin, Leda P Mannent, Yongtao Li, Shahid Siddiqui, Chien Chia Chuang, et al.

(2022) ALLERGY. 77(7). p.2211-2221
Add to list
- Journal Article
- A1
- open access
Dupilumab improves health-related quality of life : results from the phase 3 SINUS studies

Stella E Lee, Claire Hopkins, Joaquim Mullol, Jérôme Msihid, Isabelle Guillemin, Nikhil Amin, Leda P Mannent, Yongtao Li, Shahid Siddiqui, Chien-Chia Chuang, et al.

(2022) ALLERGY. 77(7). p.2211-2221
Add to list
- Conference Paper
- C3
Dupilumab achieves durable reduction in severity of symptoms rated most important by patients with chronic rhinosinusitis with nasal polyps

Claire Hopkins, Stella Lee, Wytske Fokkens, Eugene Chang, Jérôme Msihid, Asif H. Khan, Urvi Mujumdar, Siddhesh Kamat, Scott Nash, Shahid Siddiqui, et al.

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 149(2). p.AB142-AB142
Add to list
- Journal Article
- A1
- open access
Dupilumab in CRSwNP : responder analysis using clinically meaningful efficacy outcome thresholds

Chien‐Chia Chuang, Isabelle Guillemin, Claus Bachert (UGent) , Stella E. Lee, Peter Hellings (UGent) , Wytske J. Fokkens, Nicolas Duverger, Chunpeng Fan, Nadia Daizadeh, Nikhil Amin, et al.

(2022) LARYNGOSCOPE. 132(2). p.259-264
Add to list
- Conference Paper
- C3
Dupilumab leads to reduction of anosmia in patients with severe chronic rhinosinusitis with nasal polyps

Andrew Lane, Joaquim Mullol, Claire Hopkins, Wytske Fokkens, Stella Lee, Asif H. Khan, Jérôme Msihid, Scott Nash, Shahid Siddiqui, Urvi Mujumdar, et al.

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 149(2). p.AB144-AB144

Academic Bibliography

Dupilumab efficacy across serum IgE and blood eosinophil levels in chronic rhinosinusitis with nasal polyposis

Dupilumab provides early and durable improvement of symptoms in patients with chronic rhinosinusitis with nasal polyps

Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma

Response to comment on : Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma (Respir. Med. 2020)

Development of Sinonasal Outcome Test (SNOT-22) domains in chronic rhinosinusitis with nasal polyps

Dupilumab improves health related quality of life : results from the phase 3 SINUS studies

Dupilumab improves health-related quality of life : results from the phase 3 SINUS studies

Dupilumab achieves durable reduction in severity of symptoms rated most important by patients with chronic rhinosinusitis with nasal polyps

Dupilumab in CRSwNP : responder analysis using clinically meaningful efficacy outcome thresholds

Dupilumab leads to reduction of anosmia in patients with severe chronic rhinosinusitis with nasal polyps

Contents

Support

Contact